Acta Med. 2020, 63: 91-93
https://doi.org/10.14712/18059694.2020.24
Thyrotoxic Hypokalemic Periodic Paralysis Triggered by Dexamethasone Administration
References
1. AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006; 91: 2490–5.
<https://doi.org/10.1210/jc.2006-0356>
2. A, Ashwath G, Thimmappa D. Thyrotoxic periodic paralysis: clinical challenges. J Thyroid Res 2014; 2014: 649502.
<https://doi.org/10.1155/2014/649502>
<PubMed>
3. RM, Lindsey SC, Dias da Silva MR. Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 2011; 7: 657–67.
<https://doi.org/10.1038/nrendo.2011.58>
4. DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26: 1343–421.
<https://doi.org/10.1089/thy.2016.0229>
5. CC, Cheng CJ, Sung CC, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol 2013; 169: 529–36.
<https://doi.org/10.1530/EJE-13-0381>
<PubMed>
6. E, Seheult J, Gibney J, Boran G. Does thyrotoxic periodic paralysis have a genetic predisposition? A case report. Ann Clin Biochem 2018; 55: 713–6.
<https://doi.org/10.1177/0004563218785395>
7. R, McCalley S, Sule AA. Steroids and Thyrotoxicosis Precipitate Periodic Paralysis. Cureus 2018; 10: e2106.
8. S, Buranasupkajorn P, Sridama V, Snabboon T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med 2007; 46: 1431–3.
<https://doi.org/10.2169/internalmedicine.46.0044>


